Valuation: Conavi Medical Corp.

Market Cap 2.83Cr 2.04Cr 1.76Cr 1.65Cr 1.5Cr 194.92Cr 2.88Cr 19Cr 7.58Cr 98Cr 7.65Cr 7.49Cr 324.38Cr P/E 2024 *
-
P/E 2025 -1.88x
Enterprise Value 4.24Cr 3.05Cr 2.64Cr 2.48Cr 2.25Cr 291.84Cr 4.31Cr 29Cr 11Cr 146.14Cr 11Cr 11Cr 485.66Cr EV / Sales 2024 *
-
EV / Sales 2025 7.18x
Free-Float
66.52%
Yield 2024 *
-
Yield 2025 -
1 day+6.99%
1 week+59.59%
Current month+62.96%
1 month+40.58%
3 months+9.65%
6 months-27.74%
Current year-33.31%
1 week 0.11
Extreme 0.11
0.22
1 month 0.1
Extreme 0.1021
0.22
Current year 0.1
Extreme 0.1021
0.43
1 year 0.1
Extreme 0.1021
0.56
3 years 0
Extreme 0.0007
1
5 years 0
Extreme 0.0007
1
10 years 0
Extreme 0.0007
1
Change 5-day change 1-year change 3-year change Capi.($)
+6.99%+59.59% - - 2.04Cr
-1.28%-0.96%+20.30%+10.08% 22TCr
-0.71%-1.13%-4.02%-20.68% 14TCr
-1.68%+4.14%-17.85%+28.66% 14TCr
+0.27%+5.11%-49.76%+0.29% 7.51TCr
-1.04%+2.10%+17.05%+14.70% 5.28TCr
+0.69%-0.51%-16.49%-15.50% 5.07TCr
-0.51%+1.75%+24.61%+18.21% 4.19TCr
-0.32%+1.31%+41.37%+44.38% 4.05TCr
-0.14%+2.68%+0.40%+4.47% 3.33TCr
Average +0.23%+1.78%+1.73%+9.40% 8.82TCr
Weighted average by Cap. -0.82%+1.23%+0.51%+7.52%

Financials

2024 2025
Net sales 21.61L 15.57L 13.45L 12.64L 11.49L 15Cr 21.97L 1.48Cr 57.9L 7.46Cr 58.47L 57.2L 25Cr 91.22L 65.73L 56.77L 53.35L 48.52L 63Cr 92.72L 6.25Cr 2.44Cr 31Cr 2.47Cr 2.41Cr 104.6Cr
Net income -4.36Cr -3.14Cr -2.71Cr -2.55Cr -2.32Cr -300.53Cr -4.43Cr -30Cr -12Cr -150.5Cr -12Cr -12Cr -500.12Cr -2.05Cr -1.48Cr -1.28Cr -1.2Cr -1.09Cr -141.37Cr -2.09Cr -14Cr -5.5Cr -71Cr -5.55Cr -5.43Cr -235.25Cr
Net Debt 8.27Cr 5.96Cr 5.15Cr 4.84Cr 4.4Cr 570.13Cr 8.41Cr 57Cr 22Cr 285.5Cr 22Cr 22Cr 948.76Cr 1.41Cr 1.01Cr 87.54L 82.26L 74.81L 97Cr 1.43Cr 9.64Cr 3.77Cr 49Cr 3.81Cr 3.72Cr 161.28Cr
Logo Conavi Medical Corp.
Conavi Medical Corp. is a Canada-based medical device company. The Company is focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. The Novasight Hybrid System is intended for intravascular imaging of coronary arteries and is indicated in patients who are candidates for transluminal interventional procedures. Its Novasight Hybrid System combines both intravascular ultrasound (IVUS) and optical coherence tomography (OCT) to enable simultaneous and co-registered imaging of coronary arteries. Hybrid IVUS and OCT imaging provides additional information over single modality imaging in complex lesions. The versatility of hybrid imaging is useful for a variety of complex percutaneous coronary interventions (PCIs), including situations where the customer may want to image large ostial lesions with IVUS but also use OCT for diseased distal lesions and/or stent assessment.
Employees
-
Date Price Change Volume
14/26/14 $0.1444 -1.47% 21,829
13/26/13 $0.1466 +4.45% 65,168
12/26/12 $0.1403 +6.35% 60,070
11/26/11 $0.1319 -1.19% 582
10/26/10 $0.1335 -3.32% 7,354

Annual profits - Rate of surprise